HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sialoglycoprotein of vesicular stomatitis virus: role of the neuraminic acid in infection.

Abstract
Neuraminidase free of proteolytic activity substantially reduced the infectivity of vesicular stomatitis (VS) virus but less effectively than trypsin. The only sugar residue hydrolyzed by neuraminidase was N-acetyl neuraminic acid, approximately 89% of which was liberated from virion glycoprotein and the rest from virion glycolipid. Desialylation of virion glycoprotein but not of glycolipid resulted in progressive loss of infectivity. Sialyl transferase prepared and partially purified from BHK-21 cells catalyzed resialylation by CMP-[(14)C]sialic acid of the glycoprotein of neuraminidase-treated VS virions and supersialylation of unhydrolyzed VS viral glycoprotein. Resialylation of desialylated VS virions resulted in substantial (26-fold) restoration of their infectivity. We conclude that terminal neuraminic acids of VS viral sialoglycoprotein play an important role in initiation of infection with this virus.
AuthorsR H Schloemer, R R Wagner
JournalJournal of virology (J Virol) Vol. 14 Issue 2 Pg. 270-81 (Aug 1974) ISSN: 0022-538X [Print] United States
PMID4367903 (Publication Type: Journal Article)
Chemical References
  • Carbon Radioisotopes
  • Glycoproteins
  • Neuraminic Acids
  • Viral Proteins
  • Tritium
  • Transferases
  • Neuraminidase
  • Trypsin
Topics
  • Animals
  • Carbon Radioisotopes
  • Cell Line
  • Cricetinae
  • Electrophoresis, Polyacrylamide Gel
  • Glycoproteins (analysis, pharmacology)
  • Hydrolysis
  • Kidney
  • Neuraminic Acids (pharmacology)
  • Neuraminidase (metabolism)
  • Transferases (metabolism)
  • Tritium
  • Trypsin (metabolism)
  • Vesicular stomatitis Indiana virus (analysis, pathogenicity)
  • Viral Proteins (analysis, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: